CFZ013 Weekly
Research payments
$871,743
Through program year 2021, $871,743 in research payments was reported against CFZ013 Weekly, across 64 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $89,033 | 3 |
| 2020 | Research | $256,135 | 16 |
| 2019 | Research | $526,575 | 45 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Tibor Kovacsovics Portland, OR Named on 6 payments
- Noopur Raje Boston, MA Named on 6 payments
- David Vesole Hackensack, NJ Named on 5 payments
- Melissa Alsina Tampa, FL Named on 4 payments
- Noa Biran Hackensack, NJ Named on 3 payments
- Carl Landgren New York, NY Named on 3 payments
- Ruben Niesvizky New York, NY Named on 3 payments
- Jesus Berdeja Nashville, TN Named on 3 payments
- Gary Schiller Los Angeles, CA Named on 3 payments
- William Bensinger Seattle, WA Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.